Kreysun Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 10.63%
- Profit Growth 9.32%
- Ebitda 230.25%
- Net Worth 37.16%
- Total Assets 17.16%
About Kreysun Pharmaceutical
Kreysun Pharmaceutical Private Limited (KPPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 May 2016 (Eight years and nine months 12 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Absipuram Karunakar and Absipuram Prasoona serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999TG2016PTC109600
- Company No.
109600
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 May 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
What products or services does Kreysun Pharmaceutical Private Limited offer?
Kreysun Pharmaceutical Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Capsules, Sexual Wellness Products, Fertility Enhancer, Nutraceuticals & Dietary Supplements, Nutritional Supplements, Ayurvedic,Herbal Products & Medicine, Ayurvedic Herbal Syrups & Tonics, Cardiovascular Drugs & Medication, Diabetes Medicine.
Who are the key members and board of directors at Kreysun Pharmaceutical?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Absipuram Karunakar  | Director | 13-May-2016 | Current |
| Absipuram Prasoona | Director | 13-May-2016 | Current |
Financial Performance of Kreysun Pharmaceutical.
Kreysun Pharmaceutical Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 10.63% increase. The company also saw a slight improvement in profitability, with a 9.32% increase in profit. The company's net worth Soared by an impressive increase of 37.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kreysun Pharmaceutical?
In 2019, Kreysun Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kreysun Pharmaceutical?
Unlock and access historical data on people associated with Kreysun Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kreysun Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kreysun Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.